ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag genetics cancer neuroscience behavior biochemistry

Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
Genetic Diversity in the Brain
Ruth Williams | Oct 31, 2013 | 3 min read
Neurons within a person’s brain exhibit striking variations in DNA copy number.
Contributors
Diana Kwon | May 1, 2017 | 4 min read
Meet some of the people featured in the May 2017 issue of The Scientist.
illustration of neurons in blue with synapses lighting up
Gut Molecule Linked to Decreased Myelination in Mouse Brains
Angie Voyles Askham, Spectrum | Feb 17, 2022 | 4 min read
A study shows that a molecule produced by intestinal microbes can enter the brain and that its presence is also associated with altered brain connectivity.
Those We Lost in 2018
Ashley Yeager | Dec 26, 2018 | 10+ min read
The scientific community said goodbye to a number of leading researchers this year.
Mapping Brain Proteins
Devika G. Bansal | Feb 1, 2018 | 7 min read
Researchers are using souped-up mass spectrometry to localize proteins within brain cells.
Time, Flies
Anna Azvolinsky | Nov 1, 2016 | 9 min read
By studying the sleep-wake cycle of fruit flies, Amita Sehgal is revealing how the body’s circadian and sleep rhythms are regulated.
Top 10 Innovations 2013
The Scientist | Dec 1, 2013 | 10+ min read
The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.
Biotech Industry Gearing Up For More Science, Less Hype
Franklin Hoke | Jun 21, 1992 | 6 min read
But it's still unclear which new approaches in human therapeutics will pay off big; cancer and neuroscience are among the contenders Despite the enormous amount of money invested in research and development of biotechnology-derived human therapeutics in the past two decades or so, biotech industry participants and observers say the future is still unclear. Only 21 biotech drugs have been released so far, and many of those are bioengineered versions of substances that have been known and used

Run a Search

ADVERTISEMENT